Today: 20 December 2025
Subscribe

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Meta’s Chief AI Scientist Yann LeCun to Exit and Launch New AI Startup — What It Means for Meta, Open‑Source AI, and the Race to AGI (Nov. 11, 2025)

Meta’s Chief AI Scientist Yann LeCun to Exit and Launch New AI Startup — What It Means for Meta, Open‑Source AI, and the Race to AGI (Nov. 11, 2025)

Meta’s longtime chief AI scientist, Yann LeCun, is planning to leave the company to found a new artificial‑intelligence startup, according to reports published today. The move, which comes amid a sweeping reorganization of Meta’s AI efforts, would mark the most
11 November 2025
 ·  ·  ·  · 
Dogecoin vs. Shiba Inu Today (Nov. 11, 2025): Live Price, ETF Countdown, and That $2.2 Call—Can DOGE Really Make You a Millionaire by 2026?

Dogecoin vs. Shiba Inu Today (Nov. 11, 2025): Live Price, ETF Countdown, and That $2.2 Call—Can DOGE Really Make You a Millionaire by 2026?

What’s new today (Nov. 11, 2025) The $2.2 Dogecoin prediction—signal or sizzle? A widely circulated TradingView/NewsBTC note revives the “third wave” idea: after long consolidations in 2017 and 2021, DOGE could be coiling for another parabolic run—an analyst projects a
11 November 2025
 ·  ·  ·  · 
Canada Goose (GOOS): Fresh 13F Moves, Buyback Launch, and New Analyst Targets — What Investors Need to Know Today (Nov. 11, 2025)

Canada Goose (GOOS): Fresh 13F Moves, Buyback Launch, and New Analyst Targets — What Investors Need to Know Today (Nov. 11, 2025)

What changed today (Nov. 11, 2025) The most recent developments as of Tuesday, Nov. 11 revolve around post‑earnings positioning and new sell‑side targets. Barclays cut its 12‑month price target to $11 while maintaining Equal‑Weight, citing a more cautious view after
11 November 2025
 ·  ·  ·  ·  · 
CoreWeave (CRWV) stock slips after Q3 beat as data‑center delay trims 2025 outlook — What to know today (Nov. 11, 2025)

CoreWeave (CRWV) stock slips after Q3 beat as data‑center delay trims 2025 outlook — What to know today (Nov. 11, 2025)

CoreWeave, Inc. (Nasdaq: CRWV) shares moved lower in early trading Tuesday after the AI‑infrastructure provider said a third‑party data‑center delay will push some capacity online later than planned, prompting a slight cut to its full‑year outlook. The caution overshadowed otherwise
11 November 2025
 ·  ·  ·  ·  · 
Italian Pasta at Risk: Trump’s 107% Tariff Threat Could Pull 13 Brands From U.S. Shelves — What’s Changing Today (Nov. 11, 2025)

Italian Pasta at Risk: Trump’s 107% Tariff Threat Could Pull 13 Brands From U.S. Shelves — What’s Changing Today (Nov. 11, 2025)

What changed — and why pasta is suddenly in the crosshairs The U.S. Department of Commerce released preliminary results on Sept. 4, 2025, in its long‑running anti‑dumping review of “certain pasta from Italy.” Commerce assigned 91.74% dumping margins to La
11 November 2025
 ·  ·  ·  · 
Bank of America Bets Big on Wealth: Merrill Targets $150B a Year in New Assets and a 30% Margin as Moynihan Sees ‘Huge Opportunity’

Bank of America Bets Big on Wealth: Merrill Targets $150B a Year in New Assets and a 30% Margin as Moynihan Sees ‘Huge Opportunity’

Bank of America is doubling down on wealth management. Less than a week after its first Investor Day since 2011, the bank’s leadership is telegraphing an aggressive plan to grow Merrill’s fee‑generating assets by as much as $150 billion annually
11 November 2025
 ·  ·  ·  ·  · 
Eli Lilly (LLY) Pops on Fresh Deal Spree: MeiraGTx Gene Therapy Tie‑Up, New AI Collaboration, and Leerink Upgrade — Nov. 10, 2025

Eli Lilly (LLY) Pops on Fresh Deal Spree: MeiraGTx Gene Therapy Tie‑Up, New AI Collaboration, and Leerink Upgrade — Nov. 10, 2025

Eli Lilly and Company (NYSE: LLY) opened the week with a burst of dealmaking and Wall Street momentum. The pharma giant announced a rights deal for a pediatric blindness gene therapy from MeiraGTx, unveiled a new AI‑driven discovery partnership, and
10 November 2025
 ·  ·  ·  ·  ·  ·  ·  · 
Wendy’s to Close 200–350 U.S. Restaurants as ‘Project Fresh’ Accelerates — What We Know Today (Nov. 10, 2025)

Wendy’s to Close 200–350 U.S. Restaurants as ‘Project Fresh’ Accelerates — What We Know Today (Nov. 10, 2025)

Wendy’s will shutter a mid‑single‑digit percentage of its U.S. restaurants, equal to roughly 200–350 locations, as part of a turnaround dubbed “Project Fresh.” Here’s the latest for Monday, Nov. 10. Nation’s Restaurant News+1 What’s new today (Nov. 10) Industry outlets
10 November 2025
 ·  ·  ·  ·  · 
CoreWeave (CRWV) Q3 Earnings Today: 5 Things to Watch as AI Trade Wobbles — Revenue, RPO, Power Capacity, and Big‑Tech Deals

CoreWeave (CRWV) Q3 Earnings Today: 5 Things to Watch as AI Trade Wobbles — Revenue, RPO, Power Capacity, and Big‑Tech Deals

As of 16:03 UTC, CRWV traded around $105.12, up roughly 1.1% intraday, ahead of results due after today’s close. The company has confirmed its Q3 FY2025 earnings release and webcast for Monday, Nov. 10. CoreWeave Why today’s print matters After
10 November 2025
 ·  ·  ·  ·  · 
1 … 56 57 58 59 60 … 232
Go toTop